AGIO logo

Agios Pharmaceuticals (AGIO) Net Income

Annual Net Income

$673.73 M
+$1.03 B+291.35%

December 31, 2024


Summary


Performance

AGIO Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAGIOprofitabilitymetrics:

Quarterly Net Income

-$96.52 M
-$1.04 B-110.18%

December 31, 2024


Summary


Performance

AGIO Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAGIOprofitabilitymetrics:

TTM Net Income

$673.73 M
-$583.00 K-0.09%

December 31, 2024


Summary


Performance

AGIO TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAGIOprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

AGIO Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+291.4%-0.6%+291.4%
3 y3 years-58.0%-0.6%+291.4%
5 y5 years+263.7%-0.6%+291.4%

AGIO Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-58.0%+291.4%-110.2%at low-58.0%+282.1%
5 y5-year-58.0%+263.7%-105.2%+5.7%-58.0%+263.7%
alltimeall time-58.0%+263.7%-105.2%+12.2%-58.0%+263.7%

Agios Pharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Dec 2024
$673.73 M(-291.4%)
-$96.52 M(-110.2%)
$673.73 M(-0.1%)
Sep 2024
-
$947.91 M(-1086.2%)
$674.31 M(-284.8%)
Jun 2024
-
-$96.12 M(+17.9%)
-$364.93 M(+3.5%)
Mar 2024
-
-$81.55 M(-15.0%)
-$352.62 M(+0.2%)
Dec 2023
-$352.09 M(+51.9%)
-$95.94 M(+5.1%)
-$352.09 M(+60.3%)
Sep 2023
-
-$91.32 M(+9.0%)
-$219.62 M(+4.6%)
Jun 2023
-
-$83.81 M(+3.4%)
-$210.04 M(-3.7%)
Mar 2023
-
-$81.02 M(-321.8%)
-$218.04 M(-5.9%)
Dec 2022
-$231.80 M(-114.4%)
$36.53 M(-144.7%)
-$231.80 M(-36.1%)
Sep 2022
-
-$81.75 M(-11.0%)
-$362.95 M(-1.9%)
Jun 2022
-
-$91.81 M(-3.1%)
-$369.97 M(+1.5%)
Mar 2022
-
-$94.77 M(+0.2%)
-$364.38 M(-122.7%)
Dec 2021
$1.60 B(-590.2%)
-$94.63 M(+6.6%)
$1.60 B(+0.2%)
Sep 2021
-
-$88.77 M(+3.0%)
$1.60 B(+0.6%)
Jun 2021
-
-$86.22 M(-104.6%)
$1.59 B(+0.3%)
Mar 2021
-
$1.87 B(-2019.3%)
$1.59 B(-584.8%)
Dec 2020
-$327.37 M(-20.4%)
-$97.66 M(-1.3%)
-$327.37 M(-1.4%)
Sep 2020
-
-$98.98 M(+9.4%)
-$332.06 M(-2.1%)
Jun 2020
-
-$90.48 M(+124.8%)
-$339.26 M(-5.4%)
Mar 2020
-
-$40.26 M(-60.7%)
-$358.65 M(-12.8%)
Dec 2019
-$411.47 M(+18.9%)
-$102.35 M(-3.6%)
-$411.47 M(+2.6%)
Sep 2019
-
-$106.17 M(-3.4%)
-$400.92 M(+3.0%)
Jun 2019
-
-$109.87 M(+18.0%)
-$389.41 M(+11.8%)
Mar 2019
-
-$93.08 M(+1.4%)
-$348.28 M(+0.7%)
Dec 2018
-$346.03 M
-$91.79 M(-3.0%)
-$346.03 M(+1.0%)
Sep 2018
-
-$94.66 M(+37.7%)
-$342.52 M(+5.4%)
DateAnnualQuarterlyTTM
Jun 2018
-
-$68.75 M(-24.3%)
-$324.99 M(-4.2%)
Mar 2018
-
-$90.83 M(+2.9%)
-$339.33 M(+7.8%)
Dec 2017
-$314.67 M(+58.5%)
-$88.28 M(+14.5%)
-$314.67 M(+11.2%)
Sep 2017
-
-$77.14 M(-7.2%)
-$282.87 M(+5.3%)
Jun 2017
-
-$83.08 M(+25.6%)
-$268.57 M(+11.2%)
Mar 2017
-
-$66.17 M(+17.1%)
-$241.44 M(+21.6%)
Dec 2016
-$198.47 M(+68.6%)
-$56.49 M(-10.1%)
-$198.47 M(+8.7%)
Sep 2016
-
-$62.83 M(+12.3%)
-$182.61 M(+14.1%)
Jun 2016
-
-$55.95 M(+141.2%)
-$160.03 M(+17.7%)
Mar 2016
-
-$23.20 M(-42.9%)
-$135.97 M(+15.5%)
Dec 2015
-$117.73 M(+120.0%)
-$40.62 M(+0.9%)
-$117.73 M(+13.5%)
Sep 2015
-
-$40.26 M(+26.2%)
-$103.78 M(+73.5%)
Jun 2015
-
-$31.90 M(+543.5%)
-$59.81 M(+29.4%)
Mar 2015
-
-$4.96 M(-81.4%)
-$46.21 M(-13.6%)
Dec 2014
-$53.50 M(+35.8%)
-$26.66 M(-819.9%)
-$53.50 M(+36.4%)
Sep 2014
-
$3.70 M(-120.2%)
-$39.22 M(-27.5%)
Jun 2014
-
-$18.30 M(+49.4%)
-$54.10 M(+21.8%)
Mar 2014
-
-$12.25 M(-1.1%)
-$44.43 M(+12.7%)
Dec 2013
-$39.41 M(+96.0%)
-$12.38 M(+10.8%)
-$39.41 M(+21.9%)
Sep 2013
-
-$11.18 M(+29.7%)
-$32.34 M(+25.3%)
Jun 2013
-
-$8.62 M(+19.3%)
-$25.81 M(+13.7%)
Mar 2013
-
-$7.23 M(+36.0%)
-$22.70 M(+12.9%)
Dec 2012
-$20.10 M(-15.2%)
-$5.31 M(+14.4%)
-$20.10 M(+35.9%)
Sep 2012
-
-$4.64 M(-15.7%)
-$14.79 M(+45.8%)
Jun 2012
-
-$5.51 M(+19.0%)
-$10.14 M(+119.0%)
Mar 2012
-
-$4.63 M
-$4.63 M
Dec 2011
-$23.71 M
-
-

FAQ

  • What is Agios Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Agios Pharmaceuticals?
  • What is Agios Pharmaceuticals annual net income year-on-year change?
  • What is Agios Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Agios Pharmaceuticals?
  • What is Agios Pharmaceuticals quarterly net income year-on-year change?
  • What is Agios Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Agios Pharmaceuticals?
  • What is Agios Pharmaceuticals TTM net income year-on-year change?

What is Agios Pharmaceuticals annual net profit?

The current annual net income of AGIO is $673.73 M

What is the all time high annual net income for Agios Pharmaceuticals?

Agios Pharmaceuticals all-time high annual net profit is $1.60 B

What is Agios Pharmaceuticals annual net income year-on-year change?

Over the past year, AGIO annual net profit has changed by +$1.03 B (+291.35%)

What is Agios Pharmaceuticals quarterly net profit?

The current quarterly net income of AGIO is -$96.52 M

What is the all time high quarterly net income for Agios Pharmaceuticals?

Agios Pharmaceuticals all-time high quarterly net profit is $1.87 B

What is Agios Pharmaceuticals quarterly net income year-on-year change?

Over the past year, AGIO quarterly net profit has changed by -$583.00 K (-0.61%)

What is Agios Pharmaceuticals TTM net profit?

The current TTM net income of AGIO is $673.73 M

What is the all time high TTM net income for Agios Pharmaceuticals?

Agios Pharmaceuticals all-time high TTM net profit is $1.60 B

What is Agios Pharmaceuticals TTM net income year-on-year change?

Over the past year, AGIO TTM net profit has changed by +$1.03 B (+291.35%)